New Insights Reveal Untreated Sleep Apnea Doubles the Risk of Parkinson’s Disease and Highlights the Protective Benefits of CPAP Therapy

Recent medical findings have significantly advanced our understanding of the intersection between sleep disorders and neurodegenerative conditions. A comprehensive, large-scale study published on November 24 in JAMA Neurology has revealed that individuals suffering from untreated obstructive sleep apnea (OSA) face a substantially heightened likelihood of developing Parkinson’s disease. However, the research also offers a promising countermeasure: the consistent use of continuous positive airway pressure (CPAP) therapy can markedly mitigate this risk by safeguarding sleep quality and ensuring steady, uninterrupted airflow throughout the night.

Led by a dedicated team of researchers from Oregon Health & Science University (OHSU) and the Portland VA Health Care System, the study analyzed the extensive electronic health records of more than 11 million U.S. military veterans who received medical care through the Department of Veterans Affairs (VA) across a 23-year span from 1999 to 2022. This massive dataset allowed investigators to perform robust statistical analyses, offering unprecedented insight into the long-term neurological consequences of chronic sleep disorders.

Background and Context of the Research

Parkinson’s disease is a progressive, chronic neurological disorder characterized by the gradual loss of dopamine-producing neurons in the brain, leading to tremors, rigidity, balance issues, and slowed movement. It currently impacts an estimated 1 million people across the United States. While the exact etiology of Parkinson’s remains complex and multifaceted—involving a combination of genetic predispositions and environmental triggers—epidemiological data clearly demonstrates that the probability of developing the disease increases progressively with age, particularly after a person turns 60.

In recent years, the medical community has increasingly focused on the critical role that sleep plays in neurological maintenance. Sleep is not merely a period of physical rest; it is an active, vital state during which the brain clears metabolic waste products, repairs cellular damage, and consolidates memory. Disruptions to this delicate nightly maintenance routine have increasingly been linked to cognitive decline and neurodegeneration.

Obstructive sleep apnea is a prevalent sleep disorder defined by repeated episodes of upper airway collapse during slumber. These interruptions cause a person to stop breathing for brief periods, which in turn triggers sudden micro-awakenings as the brain scrambles to restore airflow. These episodes cause frequent sleep fragmentation and dangerous drops in blood oxygen saturation levels. Until now, while the immediate cardiovascular and metabolic consequences of sleep apnea—such as hypertension, stroke, and type 2 diabetes—were well documented, its long-term impact on central nervous system pathology required deeper investigation.

Methodology and Key Statistical Findings

To evaluate the relationship between sleep apnea and Parkinson’s disease, the research team at OHSU and the Portland VA tapped into the vast repository of the Veterans Affairs health care system. By examining electronic health records spanning over two decades, the investigators tracked millions of patients diagnosed with sleep apnea to observe how the management of the condition—specifically through the use of CPAP therapy—correlated with subsequent neurological diagnoses.

The findings were striking. Even after stringently adjusting for key confounding variables that typically heighten the risk of both sleep apnea and neurodegenerative disorders—such as advanced age, obesity, and hypertension—the researchers uncovered a potent association. Among the millions of veterans studied, individuals with sleep apnea who did not use CPAP therapy were found to be nearly twice as likely to be diagnosed with Parkinson’s disease compared to those who adhered to prescribed CPAP treatment.

Co-author Dr. Gregory Scott, M.D., Ph.D., an assistant professor of pathology in the OHSU School of Medicine and a staff pathologist at the Portland VA, emphasized that while the correlation is powerful, it does not represent an absolute certainty. "It’s not at all a guarantee that you’re going to get Parkinson’s, but it significantly increases the chances," Dr. Scott noted, contextualizing the statistical findings for patients and clinicians alike.

Mechanisms: How Sleep Apnea Damages the Brain

To understand why untreated sleep apnea might pave the way for Parkinson’s disease, researchers point to the physiological toll that chronic nocturnal hypoxia—low oxygen levels—takes on neural tissue. Lead author Dr. Lee Neilson, M.D., an assistant professor of neurology at OHSU and a staff neurologist at the Portland VA, explained the underlying cellular vulnerabilities.

"If you stop breathing and oxygen is not at a normal level, your neurons are probably not functioning at a normal level either," Dr. Neilson stated. The human brain is exceptionally demanding, consuming roughly 20 percent of the body’s oxygen supply despite accounting for a small fraction of total body weight. When oxygen delivery is repeatedly compromised night after night, neurons experience metabolic stress, oxidative damage, and inflammation.

Over extended periods—spanning years or even decades—this cumulative cellular stress can impair the brain’s structural integrity and resilience. "Add that up night after night, year after year, and it may explain why fixing the problem by using CPAP may build in some resilience against neurodegenerative conditions, including Parkinson’s," Dr. Neilson added. By restoring continuous oxygen flow and eliminating the cycles of hypoxia and micro-arousals, CPAP therapy likely preserves the brain’s internal environment, shielding vulnerable neural pathways from premature degeneration.

Clinical Implications and Changing Medical Practices

The implications of this landmark study extend far beyond statistical correlations; they hold the potential to directly transform clinical practice and patient care paradigms. For neurologists and primary care physicians, sleep health must no longer be treated as an isolated lifestyle concern, but rather as an integral component of preventative neurology.

Reflecting on the study’s impact, Dr. Neilson indicated that the findings would prompt an immediate shift in his own medical approach. "I think it will change my practice," he said, noting that he intends to place a much higher priority on aggressively screening and treating sleep disorders in patients who may be at elevated risk for neurological decline.

This sentiment is echoed by broader health care analysts who suggest that integrating routine sleep apnea screenings into geriatric and neurological care could serve as a vital public health intervention. Because Parkinson’s disease typically develops over many years before overt motor symptoms manifest, identifying and correcting neurodegenerative risk factors early in life offers the best hope for delaying or even preventing the onset of disease symptoms.

Overcoming Patient Hesitancy Regarding CPAP Therapy

Despite the proven efficacy of CPAP machines in maintaining airway patency and improving daily functioning, gaining patient compliance has historically presented a challenge. Many individuals find the masks cumbersome, noisy, or uncomfortable during the initial adjustment period, leading some to abandon the therapy altogether.

However, researchers note that the lived experience of compliant patients often tells a very different story. Dr. Scott highlighted the overwhelmingly positive feedback received from veterans who successfully incorporate CPAP into their nightly routines.

"The veterans who use their CPAP love it," Dr. Scott observed. "They’re telling other people about it. They feel better, they’re less tired."

Public health advocates hope that bridging the gap between comfort and compliance will become easier as patients realize the stakes extend well beyond avoiding daytime fatigue. By communicating the newly discovered link between CPAP usage and a reduced risk of Parkinson’s disease, medical providers may find a powerful new motivator to encourage patients to persist through the initial learning curve of CPAP acclimation.

Broader Scientific Context and Interdisciplinary Collaboration

The study’s credibility is reinforced by the collaborative, interdisciplinary nature of its authorship and the rigorous financial and institutional support backing the project. The research team brought together leading clinicians and scientists from multiple prestigious academic and medical institutions. In addition to Dr. Scott and Dr. Neilson, the OHSU and Portland VA team included Isabella Montano, B.A., Dr. Jasmin May, M.D., Ph.D., Dr. Jonathan Elliott, Ph.D., and Dr. Miranda Lim, M.D., Ph.D. The study also benefited from vital contributions by Dr. Yeilim Cho, M.D., and Dr. Jeffrey Iliff, Ph.D., representing the University of Washington and the VA Puget Sound Health Care System.

Funding for this extensive undertaking was provided by a robust coalition of federal agencies, private foundations, and research trusts. The Department of Veterans Affairs supported the project through multiple grant awards, including BX005760, CX00253, I01RX004822, I01RX005371, CX002022, BX006155, and Bx006155. Additional financial backing came from the John and Tami Marick Family Foundation, the Collins Medical Trust, the National Institute on Aging of the National Institutes of Health under award P30AG066518, and the U.S. Army Medical Research Acquisition Activity in Fort Detrick, Maryland, via award numbers HT9425-24-1-0774 and HT9425-24-1-0775.

The authors noted in their disclosure statements that the opinions, interpretations, conclusions, and recommendations expressed within the published research are strictly their own and do not necessarily represent the official endorsements of the Department of Defense, the National Institutes of Health, the Department of Veterans Affairs, or any other funding organization.

Future Directions in Sleep and Neurological Research

As the medical community digests the findings published in JAMA Neurology, this study opens new avenues for future scientific inquiry. Researchers plan to investigate whether early intervention with CPAP therapy can slow the progression of symptoms in patients who have already received a preliminary diagnosis of Parkinson’s disease or other neurodegenerative disorders. Additionally, future studies may explore whether treating sleep apnea yields similar protective benefits against other cognitive disorders, such as Alzheimer’s disease and related dementias.

Ultimately, this comprehensive analysis underscores a vital takeaway for public health: prioritizing and treating sleep disorders is not merely about achieving a better night’s rest or curing daytime sleepiness. It is a fundamental strategy for long-term neurological preservation, offering millions of people a tangible pathway to protect their cognitive and physical health well into their later years.